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Expression profiling confirms role of endocytic receptor mega- tubular uptake processes, megalin-deficient mice suffer
lin in renal vitamin D3 metabolism. from tubular resorption deficiency and low-molecular
Background. The endocytic receptor megalin constitutes the weight proteinuria [9].
major pathway for clearance of low-molecular weight plasma
Recent work suggests important new functions for meg-proteins from the glomerular filtrate into the renal proximal tu-
alin that extend beyond mere clearance of proteins frombules. Furthermore, the receptor has been implicated in a num-
ber of other functions in the kidney including uptake and acti- the glomerular filtrate. Megalin was shown to mediate the
vation of 25-(OH) vitamin D3, calcium and sodium reabsorp- tubular uptake of complexes of 25-(OH) vitamin D3 with
tion as well as signal transduction. its plasma carrier, the vitamin D-binding protein (DBP)
Methods. We used genome-wide expression profiling by mi-
[10]. In megalin-deficient mice, lack of the receptor re-croarray technology to detect changes in the gene expression
sults in an inability to retrieve 25-(OH) vitamin D3/DBPpattern in megalin knockout mouse kidneys and to uncover
complexes from the glomerular filtrate and in urinarysome of the renal pathways affected by megalin deficiency.
Results. Alterations were identified in several (patho)physi- excretion of the vitamin [9, 10]. This finding indicated
ologic processes in megalin-deficient kidneys including the re- an essential role of the receptor in renal vitamin D3 ho-nal vitamin D metabolism, transforming growth factor (TGF)-1 meostasis. Other studies have demonstrated that megalinsignal transduction, lipid transport and heavy metal detoxifica-
interacts with several membrane proteins expressed intion. Most importantly, changes were detected in the mRNA
proximal tubular cells. These proteins include cubilin,levels of 25-(OH) vitamin D-24-hydroxylase and 25-(OH) vita-
min D-1-hydroxylase as well as strong up-regulation of TGF-1 a peripheral membrane protein responsible for tubular
target genes. Both findings indicate plasma vitamin D defi- retrieval of albumin [11, 12], and the apical Na/H ex-
ciency and lack of vitamin D signaling in renal tissues. changer isoform 3 (NHE3) [13]. Association of cubilin
Conclusions: Expression profiling confirms a crucial role for
with megalin is required for recycling of cubilin throughmegalin in renal vitamin D metabolism.
the endocytic compartments of the cells [11, 14]. The
significance of megalin for NHE3 activity and tubular
sodium reabsorption is unclear at present. Finally, mega-Megalin is a member of the low-density lipoprotein re-
lin has been shown to harbor binding sites for cytosolicceptor gene family highly expressed on the luminal sur-
adaptor proteins in its cytoplasmic domain [15–18]. Be-face of the proximal tubular epithelium [1–6]. It consti-
cause these adaptors also interact with components oftutes the major endocytic pathway in proximal tubules
the cellular signal transduction machinery (such as, non-for the clearance of filtered low-molecular weight plasma
receptor tyrosine kinases), megalin is suspected to di-
proteins [7–9]. Consistent with a crucial role of megalin in rectly participate in signaling in the kidney.
Megalin knockout mice represent a unique model to
test the contribution of the receptor to various physiolog-Key words: 25-(OH) vitamin D-1-hydroxylase, microarray analysis,
ical processes. Unfortunately, megalin/ mice suffer fromrenal proximal tubules, transforming growth factor-1, low density
lipoprotein. a developmental defect of the forebrain causing perinatal
lethality of most affected animals [19]. Only approxi-Received for publication April 8, 2002
mately 1 to 2% of the megalin/ animals survive theand in revised form May 30, 2002
Accepted for publication June 21, 2002 perinatal period and grow up to adulthood [9, 10]. The
small number of survivors so far precluded an in-depth 2002 by the International Society of Nephrology
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investigation of the (patho)physiologic consequences of Probes, www.probes.com) at a final concentration of
the receptor gene defect in vivo. However, recent tech- 2 g/L in 6 SSPE-T for 30 minutes at 25C, followed
nological advances in genome-wide expression profil- by 10 washes in 6 SSPE-T at 25C. An antibody ampli-
ing by microarrays now enable us to uncover pathologic fication step was added using 0.1 mg/mL goat IgG
processes in tissues based on changes in the gene expres- (Sigma, www.sigma.com) and 3 g/mL biotinylated goat
sion pattern even in smaller number of samples [20]. anti-streptavidin antibody (Vector Laboratories, www.
Using the oligonucleotide microarray technology we in- vectorlabs.com). These incubations were followed by a
vestigated the alterations in the gene expression profile staining step with a streptavidin-phycoerythrin conjugate
in kidneys from megalin-deficient as compared to wild at a final concentration of 2 g/L in 6 SSPE-T for 30
type mice. We detected changes in the gene expression minutes at 25C, followed by 10 washes in 6 SSPE-T
pattern that confirm a role of the receptor in renal vita- at 25C. The probe arrays were scanned at 560 nm using
min D metabolism. a confocal laser-scanning microscope. The readings from
the quantitative scanning were analyzed by the Affyme-
trix Gene Expression Analysis Software. For array-to-METHODS
array comparison, the readings were scaled to a global
Animals
intensity of 150, as previously published [21].
The generation of megalin-deficient mice has been
described before [19]. The animals were bred in-house Quantitative RT-PCR
and fed ad libitum a normal mouse chow diet containing Quantitative reverse transcription-polymerase chain
1% calcium, 0.7% phosphorus and 1.000 IU vitamin D3 reaction (RT-PCR) was performed on total RNA sam-
(V1126 Extrudat diet; Sniff, Sost, Germany). Littermates ples from wild type and megalin-deficient littermates us-
of heterozygous breeding were used for comparative ex- ing Taq-man technology (Applied Biosystems, www.
pression profiling at the age of 12 to 16 weeks. A total appliedbiosystems.com). The following oligonucleotides
of four experiments were performed comparing two were used for 25-(OH) vitamin D-1-hydroxylase: forward
male and two female megalin-deficient animals and their 5-TCAGATGTTTGCCTTTGCCC-3, reverse 5-TGG
matched controls. TCCTCATCGCAGCTTC-3and the probe Fam 5-AGG
CACGTGGAGCTGCGAGAAGG-3 Tamra; for 25-cRNA preparation
OH-vitamin D-24-hydroxylase: forward 5-GAGCCTGC
Total RNA was prepared from kidney tissues applying TGGAAGCTCTGT-3, reverse 5-GGTTTGATCTCT
the Trizol method (Gibco-BRL; www.lifetech.com). The
AGCCGCTGG-3 and the probe Fam 5-CCGCACAG
first and second strand cDNA synthesis was performed
AGAGCGCGCATC-3 Tamra; for C/EBP: forward 5-using the SuperScript Choice System (Life Technologies,
AAGAGCCGCGACAAGGC-3, reverse 5-GTCAGCwww.invitrogen.com), labeled cRNA was prepared using
TCCAGCACCTTGTG-3, and the probe Fam 5-AAGthe BioArray High Yield RNA Transcript Labeling Kit
ATGCGCAACCTGGAGACGCA-3 Tamra; and for(Enzo, www.enzobio.com). Biotin-labeled cytidine 5-tri-
collagen III-1: forward 5-GATGTCGTTGATGTGAphosphate (CTP) and uridine triphosphate (UTP; Enzo)
GCTG-3, reverse 5-GCAGTGGTATGTAATGTCTwere used in this reaction together with unlabeled nu-
CTGGGA-3 and the probe Fam 5-ATTCCTCAGACcleotide triphosphates (NTPs). Non-incorporated nucle-
TTCTTTCCAGCCGGG-3 Tamra.otides were removed using RNeasy columns (Qiagen,
www.qiagen.com). Determination of endocrine and TGF-1 parameters
For urine collection, mice were placed in metabolicArray hybridization and scanning
cages for 16 hours and given 10% sucrose in the drinkingFifteen micrograms of cRNA were fragmented at 94C
water to increase urine excretion. Urine samples ob-for 35 minutes in buffer containing 40 mmol/L Tris-ace-
tained were qualitatively indistinguishable from samplestate pH 8.1, 100 mmol/L KOAc, 30 mmol/L MgOAc.
collected without sucrose load as shown by total outputPrior to hybridization, the fragmented cRNA was heated
of ions, amino acids, creatinine, and by pH (not shown).to 95C for five minutes in a 6 SSPE-T hybridization
PTH 1-38 fragments in urine and plasma were measuredbuffer (1 mol/L NaCl, 10 mmol/L Tris, pH 7.6, 0.005%
by a radioimmunoassay, vitamin D3 metabolites by stan-Triton) and subsequently to 40C for five minutes before
dard competitive protein binding assay (Immundiagnos-loading onto the Affymetrix probe array cartridge. The
tik). TGF-1 levels in plasma and in kidney homogenatesprobe array (Mu11K chip B; Affymetrix, www.affymetrix.
were determined using the TGF-1 Emax Immunoassaycom) was incubated for 16 hours at 45C, consecutive
Systems (Promega, www.promega.com). Prior to analy-washing and staining steps were performed in the Affy-
sis, latent TGF-1 was activated to the immunoreactivemetrix Fluidics Station. The biotinylated cRNA was stained
with a streptavidin-phycoerythrin conjugate (Molecular form by incubation of the samples in 0.1 N HCl for 15
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minutes at room temperature, followed by neutralization of the expression levels was similar to the scattering
observed between two individual wild type or two recep-with 1 N NaOH.
tor-deficient animals, respectively (Fig. 1 A, B).
In situ hybridization Next, all genes with significantly altered expression
levels in receptor-deficient as compared to control tissueDeparaffinized sections were deproteinated in pro-
teinase K solution (10 g/mL) for 30 minutes at 20C were identified (Table 1). Only changes validated by the
Affymetrix software program as decreased (D) or in-and prehybridized for three hours at 45C in a buffer
composed of 50% formamide, 0.3 mol/L NaCl, 20 mmol/L creased (I) and seen at least in three out of the four ex-
periments were included in this analysis. Application ofTris pH 8.0, 5 mmol/L ethylenediaminetetraacetic acid
(EDTA), 1  Denhart’s solution, 10% dextran sulfate alternative software programs such as Gene Spring to
evaluate the expression data gave qualitatively identicaland 10 mmol/L dithiothreitol (DTT). Hybridization with
35S-UTP-labeled sense or antisense RNA probes (6  105 results (not shown). A total of 19 genes exhibited signifi-
cant changes in expression pattern, 6 of which were de-cpm/section) was carried out for 16 hours at 50C, fol-
lowed by washing, dehydration and exposure. RNA probes creased while 13 were increased in knockout mice. Among
the genes drastically decreased in receptor-deficient ani-were prepared by in vitro transcription of a plasmid
containing the collagen type III1 cDNA (H. Eberspae- mals was the megalin gene itself, confirming the accuracy
of the profiling experiments. Interestingly, most of thecher, UT Anderson Cancer Center, Houston, TX, USA).
genes with altered expression levels could be grouped
Immunohistology into a few distinct physiological pathways. These path-
ways include the cellular vitamin D metabolism, TGF-1Kidneys were fixed in situ by consecutive infusions
with 70 mmol/L sucrose, followed by 3% paraformalde- signal transduction, lipid transport and heavy metal de-
toxification, suggesting the involvement of megalin in ahyde in phosphate-buffered saline (PBS), and 150 mmol/L
sucrose. Cryosections (5 m) were incubated with rabbit distinct set of (patho)physiologic processes in the kidney.
Quantitative RT-PCR was employed to confirm theanti-rat collagen III1 antibody (BioLogo; 1:200 dilu-
changes in the expression pattern detected by microarraytion) for one hour at room temperature, followed by
technology. Among others, we analyzed the mRNA lev-peroxidase-conjugated anti-rabbit IgG (Dako, www.dako.
els for CCAAT/enhancer binding protein- (C/EBP),com; 1:100 dilution). Bound IgG was visualized with di-
vitamin D3-24-hydroxylase (24-HYD) and collagen typeaminobenzidine. The sections were counterstained with
III1 (COL3A1) (Fig. 2). The difference in the numberhematoxylin.
of cycles required for each PCR reaction to reach the
threshold cycle (ct) value was used to calculate the differ-
RESULTS ence in mRNA levels between wild type and receptor-
Megalin constitutes the major endocytic pathway for deficient tissues according to the standard curve method
clearance of proteins into the proximal tubules and may (2	ct) . Consistent with the microarray data, the amount
serve additional yet unrecognized functions in this tissue of mRNA for 24-HYD was reduced 9.8-fold, whereas
[22]. To identify changes in renal protein expression mRNAs for C/EBP and COL3A1 were increased 5.5-
caused by inactivation of the receptor gene, the gene ex- fold and 5.3-fold in knockout animals, respectively.
pression profiles of kidneys from megalin-deficient and 24-HYD is a key enzyme in the cellular vitamin D
control mice were compared. A total of four individual metabolism of proximal tubular cells [23]. These cells
knockout animals and their respective control littermates take up the precursor 25-OH vitamin D3 and convert it
were analyzed using the murine oligonucleotide array into two alternative metabolites. They either produce
Mu11k chip B. This chip harbors approximately 6000 the active hormone 1,25-(OH)2 vitamin D3 by action of
murine sequences, including most of the known mouse the 25-hydroxyvitamin D3-1--hydroxylase (1-HYD) or
genes. Total RNA was isolated from renal tissues, labeled 24,25-(OH)2 vitamin D3, an inactive derivative, through
and hybridized to the microarrays. The hybridization data 24-HYD. The latter pathway is chosen when sufficient
were evaluated using the Affymetrix Gene Expression 1,25-(OH)2 vitamin D3 is present in the circulation and
Analysis Software as described in the Methods section. the metabolite exerts a negative feedback control on
To obtain information on the overall changes in gene 1-HYD activity. In contrast, in a state of vitamin D
expression the expression data between two individual deficiency more 25-(OH) vitamin D3 in the kidney is
wild types (Fig. 1A), two knockouts (Fig. 1B) or one wild converted into 1,25-(OH)2 vitamin D3 and the activity
type and one knockout mouse (Fig. 1C) were compared of the catabolic enzyme 24-HYD is reduced [23].
initially. Using expression scatter analysis, no gross ab- The decrease in 24-HYD mRNA levels in megalin-
normalities in the overall gene expression pattern were deficient kidneys indicated a state of vitamin D defi-
identified when wild type and receptor-deficient animals ciency in this animal model. To confirm a concomitant
increase in 1-HYD activity, we analyzed the mRNAwere compared with each other (Fig. 1C). The scattering
Hilpert et al: Megalin in renal vitamin D3 metabolism 1675
Fig. 1. Expression scatter correlation graphs of wild-
type and megalin-deficient mouse kidneys. Genome-
wide gene expression levels were compared between
two individual wild-types (A), two individual knock-
outs (B) or one wild-type and one knockout animal
(C ). Solid lines indicate a difference in expression
level by a factor of three; dotted lines denote a differ-
ence by a factor of ten. Representative data of one out
of four expression profiling experiments are shown.
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Table 1. Genes differentially expressed in megalin-deficient as compared to control mouse kidneys
Exp. A Exp. B Exp. C Exp. D
Probe set Gene function/description GenBank Dif Fold Dif Fold Dif Fold Dif Fold N
Down-regulation in knockouts
Vitamin D metabolism
Msa.32856.0_s_at Megalin AA109196 D 29.9 D 19 D 40.9 D 12 4/4
Msa.1752.0_s_at 25-hydroxyvitamin D3 D49438 D 12.7 D 7.7 D 6.2 MD 3.7 4/4
24-hydroxylase
Others
Msa.693.0_f_at Insulin-like growth factor II M36332 NC 1.3 D 3.5 MD 3.4 D 2.8 3/4
(IGF-II)
Msa.6321.0_s_at Non-POU-domain- AA002852 D 2.4 D 1.4 D 1.4 NC 1.4 3/4
containing, octamer-
binding protein
Msa.2800.0_s_at Thiazide-sensitive Na-Cl U61085 NC 1.2 D 1.7 D 2 D 2.3 3/4
cotransporter
Msa.33222.0_f_at Similar to pyruvate kinase M AA119868 MD 1.5 MD 1.5 NC 1.9 MD 1.8 3/4
Up-regulation in knockouts
TGF-ß pathway
X52046_s_at Collagen type III alpha-I X52046 I 3.5 I 9.1 I 6.0 I 2.5 4/4
(COL3A1)
Msa.756.0_g_at HMG-CoA reductase M62766 I 3.2 I 3.3 NC 1.6 MI 1.8 3/4
X62940_s_at TGF-beta stimulated clone-22 X62940 I 1.7 I 2.1 I 1.7 NC 1.1 3/4
X54149_s_at MyD118 X54149 I 1.5 I 2.3 I 1.7 NC 1.2 3/4
Lipid transport
X81627_s_at Lipocalin-encoding gene 24p3 X81627 I 9.2 I 6.3 NC 1.9 I 2.8 3/4
Msa.2129.0_s_at SV-40 induced 24p3 W13166 I 14.7 I 8.9 I 5.5 NC 1.8 3/4
Heavy metal detox.
Msa.3025.0_s_at Ceruloplasmin U49430 MI 3.3 I 2 I 1.7 NC 1.1 3/4
V00835_f_at Metallothionein-I V00835 I 3.1 I 4.3 I 2.9 NC 6.4 3/4
Others
Msa.29071.0_s_at Pol polyprotein AA087673 I 3.2 I 18 I 30.4 I 23.5 4/4
Msa.30568.0_s_at Pol polyprotein AA097626 I 2.6 I 6.8 I 5.9 I 44.3 4/4
Msa.613.0_f_at Murine leukemia virus M17327 I 1.8 I 2 I 1.7 NC 1.7 3/4
modified polytropic
provirus
Msa.19552.0_s_at Leukemia virus (MuLV) AA013976 I 4.1 I 2.2 NC 1.4 I 11.1 3/4
endonuclease
X62600_s_at CCAAT/enhancer binding X62600 MI 2.4 I 9.9 I 5.7 I 3.5 4/4
protein (C/EBP) beta
X70296_s_at Serine protease inhibitor 4 X70296 I 3 I 2.1 I 2 NC 1.9 3/4
(Spi4)
W10325_s_at cDNA clone image: W10325 I 1.9 I 3.8 I 1.5 NC 1.8 3/4
313367 5
The table depicts all genes that are differentially expressed in 3 (N 
 3/4), or 4 out of 4 individual experiments (N 
 4/4). Abbreviations are: D, decreased in
knockouts; Dif, difference call; fold, fold change; I, increased in knockouts; MD, marginally decreased; MI, marginally increased; NC, not changed. A tilde preceding
the fold change value indicates that the expression level for the untreated sample was under the calculated noise level, therefore the fold change is an approximation.
levels of this enzyme. Because the 1-HYD gene se- 1,25-(OH)2 vitamin D3 use the same intracellular co-acti-
vators, called SMAD proteins, both signaling cascadesquence is not present on the Mu11K chip B, RT-PCR
was used to quantify the amount of the renal mRNA. modulate each other when acting on the same cell. De-
pending on the cell type, synergistic or antagonistic in-Indeed, 1-HYD mRNA levels were increased fourfold
in receptor-deficient kidneys as compared to controls fluences are possible [28]. In renal tissues, 1,25-(OH)2
vitamin D3 suppresses TGF-1 activity [29]. To test what(Fig. 3).
Another group of genes that exhibit increased lev- mechanism may be responsible for induction of TGF-1
activity in megalin knockout kidneys we investigated thisels of expression in megalin-deficient kidneys are renal
TGF-1 target genes [24–27]. These include genes for signaling pathway in more detail. Using in situ hybridiza-
tion, activation of COL3A1 gene transcription was de-COL3A1, TGF-1 stimulated clone-22, MyD118 and
3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) re- tected in cells localized in the tubulointerstitial space
and around the glomeruli (Fig. 4 A, B). No significantductase (Table 1). TGF-1 is a growth factor that plays a
central role in pathophysiological processes in the kidney signal was detected in wild type samples (Fig. 4C). In-
creased transcription in knockout mice resulted in over-leading to extracellular matrix deposition. Because sig-
nal transduction pathways through TGF-1 and through production and extracellular deposition of collagen type
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Fig. 3. Quantitative RT-PCR analysis of 25-(OH)-vitamin D3-1--
hydroxylase gene expression in mouse kidneys. The levels of 25-(OH)-
vitamin D3-1--hydroxylase (1-HYD) gene expression were evaluated
by quantitative RT-PCR in wild-type and megalin knockout mouse
kidneys as described in legend to Figure 2. Symbols are: (thin solid
line) CT; (thick solid line) KO; (dashed line) WT.
In addition, strong accumulation of the protein was de-
tected in focal areas of the renal cortex, in particular in
the perivascular and the interstitial space (Fig. 5 C, D).
No such features were observed in wild type kidneys
(Fig. 5A), or in tissue incubated with the secondary anti-
body only (Fig. 5E). The up-regulation of TGF-1 target
genes was not due to an enhanced production of the
signaling factor because no increase in renal mRNAs
for TGF-1 or TGF-2 was seen in megalin-deficient
kidneys (Table 2). Furthermore, no significant differ-
ences in the total amount of TGF-1 protein was de-
tected in plasma (10.07 0.6 ng/mL; SEM) and kidney
(109.9  62.1 pg/mg protein) of knockout animals as
compared to controls (plasma, 24.3  17.2 ng/mL; kid-
ney, 111.0  55.0 pg/mg protein). Taken together, these
observations suggested an increase in renal TGF-1 bio-
activity in megalin knockout kidneys, possibly as a conse-
quence of reduced vitamin D signaling.
An imbalance in systemic vitamin D homeostasis in
receptor-deficient animals was further confirmed whenFig. 2. Quantitative RT-PCR analysis of gene expression in mouse kid-
neys. Total RNA samples from wild-type (WT) and megalin-deficient the levels of vitamin D3 metabolites and parathyroid
mouse kidneys (KO) were analyzed by quantitative RT-PCR to test hormone (PTH) in plasma and urine were analyzed (Ta-for expression levels of CCAAT/enhancer binding protein- (C/EBP),
vitamin D-24-hydroxylase (24-HYD) and collagen type III-1 (COL3A1). ble 3). Due to the inability to reabsorb 25-OH vitamin D3/
Symbols are: (thin solid line) CT; (thick solid line) KO; (dashed line) DBP complexes from the glomerular filtrate, receptor-
WT. The threshold cycle (ct) value for each reaction is indicated by
deficient animals secreted significant amounts of 25-OHthe horizontal line; ct values for each sample are shown by the vertical
lines. The difference in ct values between wild-type and knockout RNA vitamin D3 into the urine. No 25-OH vitamin D3 was
samples was used to calculate the difference in mRNA levels (2	ct). detected in wild-type urine samples. The urinary loss ofRepresentative data of one out of three experiments are shown.
25-OH vitamin D3 resulted in a 68% reduction in the
plasma levels of the precursor hormone and, as a conse-
quence, in a 67% decrease in active 1,25-(OH)2 vitaminIII 1 protein as was demonstrated by immunohistologi-
D3. The plasma PTH levels were increased significantlycal inspection of mouse kidney sections (Fig. 5). The
indicating secondary hyperparathyroidism as a conse-overall intensity of collagen type III 1 staining was sig-
nificantly increased in receptor-deficient tissue (Fig. 5B). quence of hypovitaminosis D.
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Fig. 4. Localization of collagen type III-1 gene transcription in mega-
lin-deficient mouse kidneys. Deparaffinized sections from megalin-
deficient mouse kidneys were analyzed by in situ hybridization with
antisense probes directed against mouse collagen type III-1. Gene over-
expression was detected in interstitial cells surrounding the glomeruli
(arrows; A) and in the peritubular space (arrows; B). No signal was
seen in wild type control mice (C ). No signal was obtained with the
sense probe (not shown).
DISCUSSION
Previously, megalin-deficient mice have been shown to
be unable to take up 25-OH vitamin D3/DBP complexes
from the glomerular filtrate into proximal tubular cells.
Inhibition of the receptor in perfused rat kidneys resulted
in a significant decrease in the production of 1,25-(OH)2
vitamin D3. Lack of the receptor coincided with growth
retardation and impaired bone calcification in megalin/
Fig. 5. Immunohistological detection of collagen type III -1 in wildmice [10]. These findings strongly suggest a role for the
type and megalin-deficient mouse kidneys. Cryosections of wild typereceptor in renal vitamin D metabolism by delivering (A) and megalin-deficient kidneys (B, C, D) were analyzed for accumu-
25-OH vitamin D3 to proximal tubular cells required for lation of collagen type III -1 using immunohistology. Deposition of
the protein was detected in perivascular (arrowhead) and interstitialproduction of active 1,25-(OH)2 vitamin D3. However,
regions (arrow) of receptor-deficient (B–D) but not in control tissuemany open questions as to the significance of megalin (A). No signal was seen with application of the secondary peroxidase-
activity in systemic vitamin D metabolism remained to conjugated antibody only (E ).
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Table 2. Expression levels of TGF-1 and TGF-2 in megalin-deficient as compared to control mouse kidneys
Exp. A Exp.B Exp. C Exp. D
Probe set Gene description Dif Fold Dif Fold Dif Fold Dif Fold
Msa.1226.0_s_at TGF-1 gene 5 end and promoter region NC 1.2 NC 1.1 NC 1.1 NC 1.2
Msa.9718.0_s_at TGF-1 precursor NC 1.5 NC 1.2 NC 1.9 NC 2.1
X57413_s_at TGF-2 cDNA NC 1.2 NC 1.2 NC 1.1 NC 1.3
NC, not changed.
Table 3. Endocrine parameters in wild type and megalin-deficient mice
Genotypes
Parameters / N / N P
Plasma
25-(OH) D3 nmol/L 86.620.4 5 27.58.3 4 0.01
1,25-(OH)2 D3 pmol/L 130.042.3 5 43.317.5 4 0.01
PTH 1-38 pmol/L 49.84.4 8 68.51.8 3 0.02
Urine
25-(OH) D3 nmol/mmol creatinine ND 5 2.510.29 4 0.01a
PTH 1-38 pmol/L 87.529 8 374.048 4 0.002
Values are given as mean ( standard error of the mean). The statistical significance of the values (P) was determined by the Student t or Mann-Whitney test
(a). N, number of animals; ND, not detectable.
be addressed. For example, no data on plasma 1,25-(OH)2 This conclusion is confirmed by a concomitant decrease
in renal 24-HYD expression (Fig. 2).vitamin D3 and PTH levels were available due to the
Further support for a role of megalin in renal vitamin Dsmall number of surviving knockouts and the inability to
metabolism stems from the induction of renal TGF-1obtain enough plasma samples for measurement. Also, it
target genes in knockout mice. Different pathways resultremained unclear to what extend the urinary loss of
in activation of TGF-1 and downstream genes in the25-OH vitamin D3 in the knockout mice really impaired
kidney. The most common mechanism involves patho-renal and systemic vitamin D homeostasis. Continued
physiologic processes leading to tubulointerstitial fibrosisbreeding efforts to obtain more surviving megalin/ ani-
(TIF), a progressive degeneration characterized by extra-mals and novel technological advances in molecular phe-
cellular matrix accumulation. TIF is commonly observednotyping of animal models, now enabled us to investigate
in cases of severe renal dysfunction such as obstructivethe consequence of urinary loss of 25-OH vitamin D3/
nephropathy or glomerular sclerosis [30–32]. HallmarksDBP complexes in the megalin knockout mouse model
of the disease are the infiltration of activated monocytesin more detail. Data generated by expression profiling,
into the interstitial space. There, these cells releaseimmunohistology and endocrine analysis provide further
TGF-1 that induces transcriptional activation of down-strong evidence for a crucial role of megalin in renal
stream targets such as genes for laminin and collagens.vitamin D3 homeostasis. Our results demonstrate (a) a Most likely, this mechanism is not responsible for thesignificant decrease in plasma levels of 25-OH vitamin
induction of TGF-1 pathways in kidneys lacking mega-D3 and 1,25-(OH)2 vitamin D3 in megalin knockout mice, lin. Pathological processes leading to up-regulation of
(b) a compensatory transcriptional regulation of enzymes TGF-1 expression are characterized by dramatic histo-
in the cellular vitamin D metabolism and of renal TGF-1 logical irregularities of renal tissues including thickening
target genes, and (c) an increase in plasma PTH levels, of the basement membranes, degeneration of proximal
indicative of secondary hyperparathyroidism as a conse- tubular structures and glomerular lesions [30–32]. Such
quence of plasma vitamin D deficiency. changes do not occur in receptor-deficient kidneys as
The kidney constitutes one of the prime tissues in- shown here (Fig. 5) and in earlier studies [9, 10]. Further-
volved in the regulation of the systemic calcium and bone more, no increases in TGF-1 mRNA or protein levels
metabolism. Therefore, it represents an appropriate tar- were detected in knockout mice (Table 2). Rather, novel
get to uncover potential abnormalities in calcium homeo- findings on the interaction of signaling cascades through
stasis as a consequence of megalin deficiency. Transcrip- TGF-1 and 1,25-(OH)2 vitamin D3 suggest a more obvi-
tional up-regulation of 1-HYD indicates a status of ous reason for up-regulation of TGF-1 pathways in
plasma vitamin D deficiency and a lack of sufficient quan- megalin/ mice. TGF-1 regulates target gene tran-
scription through activation of SMAD proteins, whichtities of 1,25-(OH)2 vitamin D3 in this mouse model (Fig. 3).
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act as intracellular co-activators and transcription fac- ceptor in renal vitamin D metabolism and systemic cal-
cium homeostasis by mediating tubular uptake of thetors. SMAD 3, one component of this pathway also acts
as a cofactor to the vitamin D receptor [28]. Thus, precursor 25-OH vitamin D3 and by clearing PTH 1-38.
Additional yet unrecognized functions of the receptorTGF-1 and vitamin D signaling pathways converge on
the same intracellular activator and mutually affect each may be uncovered by further investigation of other groups
of genes differentially expressed in this mouse modelother when active on the same cell type. In the kidney,
increased signaling through 1,25-(OH)2 vitamin D3 was including lipid transport through the lipocalin 24p3 or
heavy metal detoxification.shown to reduce the activity of TGF-1 without affecting
expression of the protein [29]. In the converse situation,
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